For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
Use in humans or animals is not permitted and may be subject to federal, state, or local regulations, including the Federal Food, Drug, and Cosmetic Act
At TOSM, Dr
It is a powerful antioxidant, which helps prevent cell damage and death
Cagrilintide dosage with tirzepatide explained: how each compound is titrated, appetite effects, mechanism, and why no combination is approved